CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Safety, Pharmacokinetics and Anti-Viral Efficacy of Novel Core Protein Allosteric Modifier GLS4 in Patients with Chronic Hepatitis B: Interim Results from a 48 Weeks Phase 2a Study 会议论文
作者:  Zhang, Hong;  Zhu, Xiaoxue;  Chen, Hong;  Li, Xiaojiao;  Hu, Yue
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文
作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L.
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Preliminary safety, pharmacokinetics (PK) and efficacy results from a phase I study of CS1001, an anti-programmed death ligand-1 (PD-L1) monoclonal antibody (mAb) in patients (pts) with advanced tumors 会议论文
作者:  Shen, L.;  Cao, J.;  Gong, J.;  Ji, D.;  Qin, Z.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Drug-drug interactions prediction based on similarity calculation and pharmacokinetics mechanism 会议论文
作者:  Lu, Quan;  Zhang, Liangtao;  Chen, Jing;  Xu, Zeyuan
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue Lu-177-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2018-05-01
作者:  Zhang, Jingjing;  Niu, Gang;  Wang, Hao;  Jacobson, Orit;  Cheng, Yuejuan
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace